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The tumor suppressor protein p53 participates in DNA
repair and cell cycle regulation in response to injuries
like ultraviolet (UV) irradiation. We have previously
reported that the thymidine dinucleotide (pTpT), a
common target for DNA photoproduct formation by
UV light, mimics many effects of UV irradiation in
cultured skin-derived cells, at least in part through the
activation of p53. In this report we compare the effects
of solar-simulated irradiation and pTpT on p53 and
p53-regulated proteins involved in cellular growth
arrest and DNA repair in cultured human dermal
fibroblasts. We find that, like UV irradiation, pTpT
More than half of all human cancers, includinginvasive cutaneous squamous cell carcinomas(Brash et al, 1991) and basal cells carcinomas,contain mutations of the p53 gene (Ziegler et al,1993; Hollstein et al, 1994). The p53 nuclear
phosphoprotein has been shown generally to participate in DNA
repair and specifically to mediate cellular responses to UV irradi-
ation, a major environmental genotoxin and cutaneous carcinogen.
p53 transcriptionally upregulates at least six genes involved directly
in DNA repair, increasing the time available for repair prior to
DNA replication and cell division, and/or eliminating severely
damaged cells from the tissue: p21, MDM2, GADD45, Bax, cyclin
G, and IGF-BP3 (Ko and Prives, 1996). In addition, the genes
encoding transforming growth factor-α (TGF-α) (Shin et al, 1995),
trombospondin-1 (Dameron et al, 1994), fas/APO-1 (Owen-
Schaub et al, 1995), retinoblastoma (Rb) protein (Osifchin et al,
1994), proliferating-cell nuclear antigen (PCNA) (Shivakumar et al,
1995), EGF receptor (Deb et al, 1994), cyclin D (Chen et al, 1995),
creatine kinase (Zhao et al, 1994), and p53 itself (Deffie et al, 1993)
have also been suggested to be regulated by p53 (Levine, 1997).
The protein level and activity of p53 are induced by UV
irradiation in most cell types (Fritsche et al, 1993; Liu and Pelling,
1995; Lu et al, 1996). p53 activation upregulates the transcription
of the p21 gene (el-Deiry et al, 1993, 1995), whose 21 kDa protein
product complexes with cyclins, cyclin dependent kinases, and
PCNA. Together with p21, this complex is thought to inhibit the
cyclin-dependent kinase activity that is required for phosphorylation
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increases the levels of p53, p21, and proliferating-cell
nuclear antigen. The magnitude and time course of
the inductions are UV dose dependent and consistent
with known regulatory interactions among these nuc-
lear proteins. These data confirm and expand previous
studies of UV effects on nuclear proteins involved in
cell cycle regulation and DNA repair. Our observations
suggest that such protective effects can also be induced
by pTpT in the absense of initial DNA damage,
rendering cells more capable of responding to sub-
sequent DNA damage. Key words: p21/PCNA/pTpT/
Rb protein/ultraviolet. J Invest Dermatol 112:25–31, 1999
of the Rb gene product and progression through the cell cycle
(Harper et al, 1993; Li et al, 1994). In addition to its role in DNA
replication (Bravo et al, 1987; Prelich et al, 1987a, b), the PCNA
nuclear protein participates in nucleotide excision repair (Shivji
et al, 1992) and is found at the sites of DNA damage in cells
exposed to UV irradiation (Celis and Madsen, 1986; Toschi and
Bravo, 1988). Exposure of human skin to UV doses sufficient to
induce mild sunburn results in rapid accumulation of p53 protein
in epidermal keratinocytes and in superficial dermal fibroblasts (Hall
et al, 1993), presumably due to increased protein half-life (Maltzman
and Czyzyk, 1984). PCNA induction follows (Hall et al, 1993),
presumably through binding of p53 to the PCNA promoter,
increasing transcription of this gene (Morris et al, 1996).
Treatment of mammalian cells with a variety of DNA-damaging
agents, including UV irradiation, upregulates the capacity to repair
subsequent DNA damage (Schorpp et al, 1984; Lehmann and
Oomen., 1985; Klocker et al, 1986; Protic et al, 1988). Such
damaging agents, again including UV irradiation, generate short
DNA fragments during the course of excision repair (Hoeijmakers,
1993) and interestingly, such fragments have been shown to activate
p53 at least in vitro through interaction with the C-terminal domain
of the protein (Jayaraman and Prives, 1995). These findings suggest
that some of the UV-induced effects may result from p53 activation
by single-stranded DNA fragments generated during the repair
process (Eller et al, 1994, 1996, 1997; Smith and Fornace, 1997).
In this regard, we have reported previously that small DNA
fragments, particularly thymidine dinucleotides (pTpT) but also
other oligonucleotides,1 can mimic cellular responses to UV irradi-
ation including enhanced melanogenesis (Eller et al, 1994, 1996),
increased DNA repair and reversible cell growth arrest (Eller et al,
1997), and increased tumor necrosis factor-α (TNF-α) expression
1Eller MS, Gasparro FP, Amato PE, Gilchrest BA: Induction of
melanogenesis by DNA oligonucleotides: effect of oligo size and sequence.
J Invest Dermatol 110:474, 1998 (abstr.)
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and secretion.2,3 At least some of these effects are mediated through
activation of p53 (Eller et al, 1997) and increased mRNA levels
for the responsible proteins (Eller et al, 1994, 1997), consistent
with transcriptional upregulation.
We now report that pTpT, similar to UV irradiation, upregulates
the levels of p53, PCNA, and p21, but without the requirement
for prior genomic DNA damage. Furthermore, we determine that
pretreatment with pTpT primes cells to respond more efficiently
to subsequent DNA damage, such as that caused by UV irradiation.
MATERIALS AND METHODS
Cell culture Primary human fibroblast cultures were prepared from
newborn foreskins as described (Gilchrest, 1980) and used at population
doubling ø5. For experiments, cells were maintained in Dulbecco’s
modified Eagle medium supplemented with 10% calf serum (GIBCO/
BRL, Gaithersburg, MD). Cultures were maintained at 37°C in 7% CO2.
UV irradiation Cultures were exposed to 5 and 30 mJ UVB per
cm2 through plastic culture dish lids in phosphate-buffered saline (PBS),
using a solar simulator (Spectral Energy, Westwood, NJ) as described
(Gilchrest et al, 1993). The 1 kW xenon arc lamp (XMN 1000–21;
Optical Radiation, Azuza, CA) was adjusted to 8 3 10–5 W per cm2
and metered with a research radiometer fitted with a UVB probe, at
285 6 5 nm (model IL1700 A; International Light, Newburyport, MA)
to provide a physiologic exposure (Werninghaus et al, 1991). Because
10% or less of UVB energy incident on fair Caucasian skin penetrates
to the dermo–epidermal junction, a dose of 5 mJ UVB per cm2
received by fibroblasts would correspond to an exposure of at least 50
mJ per cm2 at the skin surface, conservatively 2 minimal erythema
doses (MED); and a 30 mJ per cm2 UVB dose to ~12 MED, a
blistering sunburn dose. Sham-irradiated cultures were handled identically,
except that they were shielded with aluminum foil during the irradiation.
After irradiation, cultures were given their original medium.
Treatment with pTpT In previous experiments, 100 µM of pTpT
consistently elicited maximal or near-maximal UV mimetic responses
including melanogenesis (Eller et al, 1994), induction of tyrosinase
mRNA and upregulation of MSH binding in S91 cells (Eller et al,
1996), and p53 activation (Eller et al, 1997). Lower concentrations were
frequently less effective. Hence, fibroblasts were plated at 1.8 3 104
cells per dish and, 48 h later, cells were provided with 100 µM pTpT
(Midland Certified Reagent, Midland, TX) diluted from a 2 mM stock
solution in DME or an equal volume of diluent (DME) alone as
control. Total cellular RNA and proteins were collected at intervals up
to 5 d after stimulation.
Western blot analysis Total cellular proteins were collected in a
buffer consisting of 0.25 Tris HCl (pH 7.5), 0.375 M NaCl, 2.5%
sodium deoxycholate, 1% Triton X-100, 25 mM MgCl2, 1 mM
phenylmethyl sulfonyl flouride, and 0.1 mg aprotinin per ml as described
(Yaar et al, 1994). Protein concentrations were determined by the
method of Bradford as described (Yaar et al, 1994). One hundred
micrograms of proteins were separated over 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis as described (Yaar et al, 1994) and
transferred to a nitrocellulose membrane (Schleicher & Schuell, Keene,
NH). After transfer, the gel was stained with Coomassie Blue to verify
even loading as visualized by the residual high molecular weight proteins.
Membranes were blocked in 0.05% Tween-20/PBS with 5% milk (Bio-
Rad Laboratories, Hercules, CA). Antibody reactions were performed
with affinity purified mouse monoclonal antibodies diluted 1:500 in
0.05% Tween-20/PBS with 1% milk. The following antibodies were
used: DO-1 (Ab-6) anti-p53 (Oncogene Science, Cambridge, MA)
(Spandau, 1994), p105Rb (Ab-5) anti-retinoblastoma (Oncogene Science),
anti-PCNA (Ab-2) (Oncogene Science), and anti-p21 (Transduction
Laboratories, Lexington, KY). Horseradish peroxidase-tagged goat anti-
mouse IgG (secondary antibody) was obtained from Bio-Rad Laboratories
(Hercules, CA). Horseradish peroxidase-linked sheep anti-mouse IgG
was obtained from Amersham (Arlington Heights, IL). Secondary
2Leverkus M, Yaar M, Eller MS, Tang EH, Gilchrest BA: Thymidine
dinucleotide mimic immunomodulatory effects of ultraviolet irradiation. J
Invest Dermatol 108:559, 1997 (abstr.)
3Cruz P, Dougherty I, Eller M, Gilchrest B: Thymidine dinucleotides
inhibit the induction of contact hypersensitivity and activate the gene for
TNFα. J Invest Dermatol 110:491, 1998 (abstr.)
antibody was used at 1:2500 dilution. Antibody binding was detected
by the ECL detection kit (Amersham), followed by autoradiography
(Kodak X-Omatic AR).
Northern blot analysis Total RNA was isolated from cells with Tri-
Reagent (GIBCO/BRL, Gaithersburg, MD) following the protocol of
the manufacturer. RNA concentrations were determined by absorbance
at 260 nm. The purity of the preparations was determined by the ratio
of 260/280 readings and was consistently . 1.8. Twenty micrograms
of RNA from each sample were electrophoresed on 1% agarose gels
containing 2.2 M formaldehyde as described (Yaar et al, 1991). RNA
was transferred to nylon membranes (Hybon, Amersham), and was
immobilized by shortwave UV irradiation (UV-Stratalinker 1800,
Stratagene, La Jolla, CA) and hybridized with 32P-labeled p53 cDNA
as described previously (Eller et al, 1992), p21 cDNA, the kind gift of
Dr. J. Smith (Center on Aging, Baylor College of Medicine, Houston,
TX) (Noda et al, 1994), and GAPDH cDNA (ATCC).
Densitometric analysis Autoradiographs of western and northern
blots and Coomassie Blue stained gels were scanned (Microtek Scan
Maker II, Taiwan) into a computer (Massachusetts Engineering Group,
Boston, MA) and band intensity was determined after background
subtraction using the densitometric program ‘‘Sigma Gel’’ (Jandel
Scientific 1995). After normalization for loading of the lanes as
determined by Coomassie Blue staining (for western blots) and ethidium
bromide staining and/or GAPDH intensity (for northern blots), percentage
increases of specific proteins and mRNA transcripts were determined.
Statistical analysis To determine the significance of the change in
protein or mRNA levels as a result of UV versus sham irradiation or
pTpT versus diluent treatment, paired t tests were performed.
RESULTS
UV upregulates p21 but not p53 mRNA Fibroblasts were
sham or UV irradiated and gene expression was analyzed by
northern blotting. In three independent experiments, up to 48 h
after UV irradiation there was no significant modulation of p53
mRNA (Figs 1A, B), as previously reported by others (Rogel
et al, 1985). In contrast, compared with sham-irradiated samples,
p21 mRNA level was increased as early as 8 and 16 h after
irradiation (145% 6 22% and 273% 6 56%, respectively,
p , 0.02), was maximally induced 24 h after irradiation
(405% 6 148%, p , 0.05), and remained elevated through
36 h (218% 6 29%, p , 0.01) and 48 h (247% 6 74%,
p , 0.03) (Figs 1C, D), consistent with UV activation of
pre-existing p53 protein, as previously reported (Liu and
Pelling, 1995).
pTpT supplementation upregulates p21 mRNA but not
p53 mRNA To determine if pTpT affects p53 and p21
mRNA in the same way as UV irradiation, fibroblasts were
provided with 100 µM pTpT or diluent alone and p53 and
p21 mRNA levels were analyzed by northern blotting. In three
independent experiments, like UV irradiation, pTpT did not
modulate p53 mRNA levels (data not shown), but p21 mRNA
level was significantly increased 24 h after irradiation (169% 6 2%,
p , 0.0001), although to a lesser degree than after UV
irradiation (Figs 2A, B).
UV upregulates p53, p21, and PCNA protein levels and
inhibits Rb protein phosphorylation Human fibroblasts were
exposed to low (5 mJ per cm2) or high (30 mJ per cm2) doses
of UV irradiation (Fig 3). Similar to previous reports using
other cell types (Lu and Lane, 1993; Yamaizumi and Sugano,
1994; Maki and Howley, 1997), western blot analysis revealed
that p53 protein was upregulated at both UV doses but was
more prominently elevated after the higher dose (Figs 3A, B).
In two independent experiments at 5 mJ per cm2 and four
independent experiments at 30 mJ per cm2, p53 was induced
as early as 3 h after irradiation and remained elevated through
48 h (Fig 3B).
The p21 protein level was also induced by both UV doses.
After the low UV dose it was induced as early as 3 h after
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Figure 1. UV irradiation upregulates p21
but not p53 mRNA in normal human
fibroblasts. Fibroblasts were UV (1) or
sham (–) irradiated with 30 mJ per cm2 of
UV and processed for northern blot analysis
with sequential hybridization using cDNA
probes specific for p53, p21, and GAPDH,
followed by densitometric analysis as
described in Materials and Methods. There was
no significant modulation of p53 mRNA by
UV irradiation but p21 mRNA increased
compared with the paired sham-irradiated
control samples. One representative northern
blot is shown for p53 (A) and p21 (C).
Densitometric analysis was performed for
three independent experiments, in which
similar results were obtained (B, D).
Figure 2. pTpT upregulates p21 mRNA in normal human
fibroblasts. Fibroblasts were supplemented with 100 µM pTpT (1) or
diluent (DME) alone (–). Cells were collected at different intervals after
pTpT supplementation and RNA was processed for northern blot analysis
as detailed in the caption to Fig 1. There was a significant (p , 0.0001)
but modest elevation of p21 protein level 24 h after irradiation. One
representative northern blot is shown (A). Desitometric analysis was
performed for three independent experiments in which similar results were
obtained (B).
irradiation, was maximally elevated 7 h after irradiation, and
remained elevated through 48 h; whereas after the high UV
dose, p21 level was initially slightly decreased but progressively
increased from 7 through 48 h after irradiation (Fig 3A, C).
In sham-irradiated cells, a gradual increase of Rb phosphoryla-
tion was observed, with maximal phosphorylation at 20 h and
a decline to near basal level at 48 h (Fig 3A), possibly
representing transient growth arrest and subsequent growth
synchronization after the 10–15 min incubation in PBS at room
temperature. A similar pattern of Rb phosphorylation was
observed in cells UV irradiated with 5 mJ per cm2. In contrast,
after 30 mJ per cm2, Rb was increasingly unphosphorylated
through 48 h (Fig 3A), in apparent concordance with maximal
expresssion of p53 and p21. This is consistent with the
presumptive UV activation of the p53-dependent pathway that
blocks progression through the cell cycle (Goodrich et al, 1991).
PCNA protein level was induced after 48 h in cells irradiated
with 30 mJ per cm2 (Fig 3A).
pTpT upregulates the protein levels of p53, p21, and
PCNA Fibroblast cultures were stimulated with 100 µM pTpT
or diluent (DME) alone and processed for western blot analysis
(Fig 4A, B). After correction for loading, in two or three
independent experiments for each time point, after pTpT
addition a gradual increase in p53 protein level was observed,
133% 6 5% (p , 0.03), 192% 6 2% (p , 0.008), 156% 6 11%
(p , 0.05), and 373% 6 7% (p , 0.02) of diluent control
levels at 48, 72, 96, and 120 h, respectively. p21 protein level
did not change in diluent-treated cells, but gradually increased
in pTpT-treated cells though 72 h to 296% 6 17% (p , 0.004)
of control levels, then returned toward baseline. PCNA level
was induced at 96 h (p , 0.04) and particularly at 120 h after
pTpT stimulation (p , 0.051). Thus, like UV irradiation, pTpT
induces p53 and the p53-regulated proteins p21 and PCNA.
pTpT pre-treatment enhances DNA repair protein induc-
tion by UV irradiation Previous work in our laboratory
demonstrated that pretreatment of cells with pTpT enhances
their ability to repair DNA damage, most likely in a p53-
dependent manner (Eller et al, 1997). In order to examine the
effect of pTpT pretreatment on the p53-dependent response to
UV irradiation, fibroblasts were pretreated with 100 µM pTpT
or diluent for 5 d, and then were sham or UV irradiated with
5 mJ per cm2 and 30 mJ per cm2, as before.
In four independent experiments, during the first 20 h after
irradiation the modulation of p53, p21, and PCNA in pTpT
pretreated and control cultures was similar (data not shown);
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Figure 3. UV irradiation upregulates the
protein level of p53, p21, and PCNA
and inhibits Rb protein phosphory-
lation. Fibroblasts were UV (1) or sham
(–) irradiated with 5 mJ per cm2 or 30
mJ per cm2. Total cellular proteins were
collected at different intervals after irradiation
and 100 µg of protein was loaded per lane
and processed for western blot analysis. The
membrane was cut into strips containing
proteins of different molecular weights and
each strip was then reacted with a different
antibody directed against a protein of the
appropriate molecular weight (A). p53
protein level was upregulated after both UV
doses as early as 3 h after irradiation and
remained elevated through 48 h (B). After
the low UV dose, p21 protein level was
maximally induced 7 h after irradiation,
whereas after the high UV dose it was
maximally indcued 48 h after irradiation (C).
At all time points p53 and p21 protein levels
in irradiated cultures differed statistically from
those in control cultures (p , 0.05 to
p , 0.0001, paired t test). Similar results
after the low and high doses of UV irradiation
were obtained in two and four independent
experiments, respectively, for p53 (B), p21
(C), Rb, and PCNA.
however, in cells pretreated with pTpT and then UV irradiated
with 5 mJ per cm2 compared with diluent pretreated irradiated
cells, after 48 h p53 protein levels were comparably elevated in
both groups, but p21 protein level was almost twice as high
(135% 6 34%, p , 0.006) and PCNA protein level was nearly
four times as high (360% 6 24%, p , 0.002) (Fig 5, Table I).
The effect of pTpT pretreament was less at the higher UV
irradiation. For example, in cells pretreated with pTpT, as
compared with diluent pretreated cells, 48 h after 30 mJ per
cm2 p21 and p53 protein levels were comparably elevated,
although PCNA protein was 71% 6 7% higher, a small but
statistically significant elevation (p , 0.0001) (Fig 5, Table I).
Thus, pretreatment with pTpT enhances the induction of p53
and its regulated proteins, in particular PCNA by UV irradiation.
DISCUSSION
Accumulation of p53 protein has been observed in many
different types of cells both in vivo and in vitro after treatment
with a variety of DNA-damaging agents, including UV irradiation
(Fritsche et al, 1993; Medrano et al, 1995; Lu et al, 1996).
Using cultured human dermal fibroblasts and solar-simulated
irradiation, we have examined expression of genes and proteins
that participate in the signal transduction pathway of UV-
activated p53-dependent growth arrest and DNA repair. We
demonstrate that p53 and the p53-inducible cyclin-dependent
kinase inhibitor p21 are upregulated as early as 7 h and 20 h,
respectively, after irradiation with a large but physiologic dose
of 30 mJ per cm2 that can be delivered to the superficial dermis
of human skin on a summer afternoon (Johnson, 1984; Garmin
et al, 1992). Both p53 and p21 remain maximally elevated for
at least 48 h. The effects are UV dose dependent, and after a
lower UV dose of 5 mJ per cm2, elevation of p53 protein is
of considerably lesser magnitude. The timing and degree of p21
upregulation generally follows that of p53 at both the lower
and the higher UV doses.
p53 activity and protein level are consistently upregulated
after genotoxic injury (Hebel et al, 1986; Kastan et al, 1991),
but p53 mRNA levels have been variably reported to be either
downregulated (Lilleberg et al, 1992; Jung et al, 1997) or
upregulated (Komarova et al, 1997). In normal human fibroblasts,
we found no change in p53 mRNA level after UV irradiation,
although in the same cells we found a dramatic increase in p53
protein level. These results suggest that in human fibroblasts
UV irradiation upregulates p53 protein level by post-translational
modification such as increased protein half life, as reported
earlier for other cell types (Oren et al, 1981; Reihsaus et al,
1990; Kraiss et al, 1991), presumably due to loss of p53
ubiquitination, as shown both in vitro (Scheffner et al, 1994;
Scheffner and Nuber, 1995; Maki et al, 1997) and in vivo (Maki
et al, 1996). The clinical relevance of our finding is suggested
by the report of p53 immunoreactivity in cutaneous fibroblasts
following UV irradiation of intact skin (Hall et al, 1993).
Under basal conditions in normal cells, p53-driven transcrip-
tional activity is low (Rogel et al, 1985), consistent with the
low level of p53 protein (Oren et al, 1981). Within hours of
UV irradiation, however, we found concordant induction of
p53, p21, and PCNA levels. Interestingly, we found that at the
lower UV dose, p21 was upregulated without a substantial
increase in p53 level (see Figs 4A, B, 7h), suggesting that p53
activity as a transcription factor can be altered without increasing
p53 protein level. Such findings are consistent with the fact that
p53 is known to exist in both an inactive and a transcriptionally
active form (Hupp and Lane, 1995), and suggest different UV
damage thresholds for p53 protein activation, rate of mRNA
translation, and/or post-translational modification leading to
increased protein half-life. Post-translational modification is the
major mechanism of p53 regulation, and as it was found recently
(Chernov et al, 1998) that stabilization and activation of p53
are regulated independently by different phosphorylation events,
probably involving different kinases.
Inhibition of Rb phosphorylation occured at the same time
as the upregulation of p21 protein, consistent with activation of
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Figure 4. pTpT upregulates the protein level of p53, p21, and
PCNA in normal human fibroblasts. Fibroblasts were supplemented
with 100 µM pTpT (1) or diluent (DME) alone (–). Total cellular proteins
were collected at different intervals after pTpT supplementation, 100 µg
of protein was loaded per lane and the gel was processed for western blot
analysis (A). After normalization for loading as reflected by Coomassie
Blue staining of the residual high molecular weight proteins on the gel,
densitometric analysis of two or three independent experiments at each
time point was performed (B). Increased levels in pTpT-treated cells
compared with diluent-treated cells were observed for all three proteins.
Increases were maximal at 5 d for p53 and PCNA and at 3 d for p21.
the p53 dependent growth arrest pathway, as previously reported
for human melanocytes (Medrano et al, 1995). PCNA, a protein
required for both DNA replication and repair, was also
upregulated at 48 h, coincident with high levels of p53 and
p21. p21 is known to bind directly to PCNA and inhibit its
DNA replication function (Flores-Rozas et al, 1994; Waga et al,
1994; Podust et al, 1995; Chen et al, 1996), but not its DNA
repair function (Pagano et al, 1994; Nichols and Sancar, 1992).
Hence, the observed induction of this protein is consistent with
both the expected growth arrest after UV irradiation and active
DNA repair.
In human fibroblasts pTpT closely mimics UV response in
its modulation of p53 and p53-regulated proteins. Whether
pTpT acts only at the transcriptional level or, like UV, also at
the post-transcriptional level, cannot be determined from this
data. Jayaraman and Prives (1995) have shown that the consensus
sequence-specific DNA-binding activity of p53 is stimulated by
the binding of short single-stranded DNA fragments to a C-
terminal domain of the protein. The dinucleotide pTpT may
interact with p53 in this manner, directly stimulating p53-
mediated transcription at early time points (Chen et al, 1996),
and thus enhancing mRNA and protein levels for p21 and
Figure 5. pTpT pretreatment enhances p53, p21, and PCNA
proteins by UV irradiation in normal human fibroblasts. Fibroblasts
were pretreated with 100 µM pTpT (1) or diluent (DME) alone (–) for
5 d, and then sham (Sh) or UV irradiated with 5 mJ per cm2 or 30 mJ
per cm2. Total cellular proteins were collected 48 h after irradiation, 100
µg of protein per lane was loaded and the gel was processed for western
blotting. The last lane on the right shows samples that were treated with
diluent for 5 d and then sham irradiated. One of four representative
experiments is shown.
Table I. pTpT pretreatment enhances UV induction of
p53, p21, and PCNA
Per cent induction above diluent-treated cellsa
Protein 5 mJ per cm2 30 mJ per cm2
p53 22 6 18 8.3 6 10.6
p21 135 6 34b 17 6 8
PCNA 360 6 24b 71 6 7b
aMean 6 SD in four independent experiments.
bStatistically significant induction (p , 0.01 for p21, p , 0.035 for PCNA at 5
mJ per cm2 and p , 0.005 for PCNA at 30 mJ per cm2, paired t test).
PCNA. Regardless of its precise mechanism(s) of action, pTpT
appears to induce UV-protective responses in cultured human
fibroblasts at least in part through p53-dependent activation of
genes involved in growth control (p53 and p21) and DNA
repair (p53 and PCNA), accounting for the previously observed
effects of pTpT on critical cellular functions (Eller et al, 1997).
Finally, our experiments demonstrate that pretreatment of human
fibroblasts with pTpT for 5 d enhances induction of p53, p21,
and PCNA by subsequent UV irradiation, consistent with the
hypothesized ability of these DNA fragments to induce a broad-
based protective eukaryotic cellular response in the absence of
genotoxic injury (Eller et al, 1997). These findings also suggest
clinical utility of the repsonse in the event of subsequent DNA
damage, as previously shown for the SOS response described in
prokaryotic cells after DNA damage (Eller, 1995).
In conclusion, we demonstrate that pTpT induces proteins
that are also induced by UV irradiation and are known to
participate in protective responses such as transient growth arrest
and enhanced DNA repair, at least in part through p53-
dependent activation of downstream genes (Eller et al, 1997).
We also demonstrate that pretreatment with pTpT primes human
cells to respond more efficiently to subsequent UV irradiation,
without the requirement for prior DNA damage.
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